The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
A colorful ingredient you may find in your pantry or medicine cabinet is now banned by the Food and Drug Administration.
On January 16, the U.S. Food and Drug Administration (FDA) announced that it is revoking the authorization for use of FD&C Red No. 3 in ...
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
Kennedy Jr.’s rallying cry is what makes it so sickening. Make America Healthy Again? Like when we had more measles and ...
In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
On Wednesday, the Food and Drug Administration revoked authorization for the use of red dye No. 3 in food and ingested drugs.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
While it caused cancer in these male rats, the dye does not cause cancer in humans and other animals in the same way, ...
The colorant was banned from cosmetics and non-oral medications years ago because a study showed it caused cancer in rats.
The Trump administration has promised an overhaul of various government agencies. What will happen to the Health Department?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback